Review: could Metoprolol Tartrate cause Ventricular Tachycardia?


Ventricular tachycardia is found among people who take Metoprolol Tartrate, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Aspirin, and have Hypertension . We study 39,220 people who have side effects while taking Metoprolol tartrate from FDA and social media. Among them, 282 have Ventricular tachycardia. Find out below who they are, when they have Ventricular tachycardia and more.

You are not alone

Join a support group for people who take Metoprolol tartrate and have Ventricular tachycardia >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 40,569 users)

Ventricular Tachycardia

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) has been reported by people with electrocardiogram qt prolonged, breathing difficulty, hypotension, cardiac failure, arrhythmias (latest reports from 13,794 Ventricular tachycardia patients).

On Aug, 22, 2016

39,220 people reported to have side effects when taking Metoprolol Tartrate.
Among them, 282 people (0.72%) have Ventricular Tachycardia

Number of reports submitted per year:

Could Metoprolol tartrate cause Ventricular tachycardia?

Time on Metoprolol Tartrate when people have Ventricular Tachycardia *:

  • < 1 month: 36.36 %
  • 1 - 6 months: 9.09 %
  • 6 - 12 months: 9.09 %
  • 1 - 2 years: 27.27 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 9.09 %
  • 10+ years: 9.09 %

Gender of people who have Ventricular Tachycardia when taking Metoprolol Tartrate *:

  • female: 41.99 %
  • male: 58.01 %

Age of people who have Ventricular Tachycardia when taking Metoprolol Tartrate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.82 %
  • 30-39: 5.22 %
  • 40-49: 8.03 %
  • 50-59: 17.27 %
  • 60+: 64.66 %

Severity if Ventricular Tachycardia when taking Metoprolol Tartrate **:

  • least: 0.0 %
  • moderate: 0.0 %
  • severe: 100 %
  • most severe: 0.0 %

How people recovered from Ventricular Tachycardia **:

  • while on drug: 0.0 %
  • after off the drug: 0.0 %
  • not yet: 100 %

Top conditions involved for these people *:

  • Hypertension (35 people)
  • Atrial Fibrillation (30 people)
  • Ventricular Tachycardia (16 people)
  • Depression (14 people)
  • Multiple Myeloma (12 people)

Top co-used drugs for these people *:

  • Aspirin (61 people)
  • Lasix (58 people)
  • Digoxin (58 people)
  • Furosemide (52 people)
  • Lisinopril (42 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Ventricular tachycardia when taking Metoprolol tartrate?

Browse all side effects of Metoprolol tartrate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Ventricular tachycardia

Ventricular tachycardia

Could your condition cause Ventricular tachycardia

Ventricular tachycardia

Can you answer these questions?

More questions for: Metoprolol tartrate, Ventricular tachycardia

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Ventricular tachycardia

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.